Zynerba Pharma Cash Flow - Annual (NASDAQ:ZYNE)

Add to My Stocks
$12.39 $0.51 (4.29%) ZYNE stock closing price Jun 21, 2018 (Closing)

The financial analysis of ZYNE requires an investor to check the cash flows for Zynerba Pharma. The profit-loss statement shows Zynerba Pharma profits, the balance sheet shows Zynerba Pharma debt, and the cash flow statement reflects the liquidity and solvency of a firm. This statement reflects the company's ability to generate cash flows. Items like capital purchases, bank loan payments etc. which have a direct impact on the cash position of a company come out through the statemement of cash flows and help an investor who undertakes the Zynerba Pharma stock analysis. Zynerba Pharma generated $-25.84M cash from operating activities in 2017. ZYNE decrease in investments stood at a value of $-0.11M for the latest year 2017.

View details of Zynerba Pharma cash flows for latest & last 10 financial years
show more
Fiscal year is Jan - Dec20172016201520142013
Net Income Cash Flow
-32.01M-23.38M-12.55M-5.66M-0.63M
Depreciation Depletion Amortization Cash-Flow-----
Net Increase (Decrease) in Assets Liabilities--0.49M1.13M--
Cash From (used in) Discontinued Operations-----
Other Adjustments Net5.64M3.36M1.6M1.9M-
Net Cash from (used by) Operating Activities
-25.84M-20.43M-9.78M-3.54M-0.11M
Increase (Decrease) in Prop Plant And Equipment-0.11M-0.1M-0.21M-0.01M-
Acquisition Disposition of Subsidiaires-----
Increase (Decrease) in Investments-----
Other Cash Inflow (Outflow) from Investment Activities-----
Net Cash from (used by) Investment Activities
-0.11M-0.1M-0.21M-0.01M-
Issuance (Purchase) of Equity Shares57.72M10M42.18M13.23M-
Issuance (Repayment) of Debt Securities----0.49M-
Increase (Decrease) in Bank & Other Borrowings-----
Payment of Dividends & Other Cash Distributions-----
Other Cash from (used by) Financing Activities-0.22M----
Net Cash from (used by) Financing Activities
57.5M10M42.18M12.73M-
Effect of Exchange Rate Changes on Cash-----
Net Change in Cash & Cash Equivalents
31.54M-10.54M32.18M9.17M-0.01M
Cash & Equivalents at Beginning of Year30.96M41.51M9.33M--
Cash & Equivalents at Year End62.51M30.96M41.51M9.33M-
All figures in USD. M: Millions of USD, B: Billions of USD.

Zynerba Pharma stock price history provides insight into historical stock price fluctuations, and Zynerba Pharma stock comparison chart enables peer comparison. Some of the key terms used in the statement of cash flows are:

  • Zynerba Pharma saw a positive change in Net Change in Cash and Cash Equivalents of $31.54M in 2017. Apart from the Zynerba Pharma stock price, this is one of the things an investor looks for, as it shows the net change in cash on hand for a company, compared to previous period.
  • Cash Flow from operating activities: Zynerba Pharma reported a negative operating cash flow of $-25.84M for 2017 and has seen a decrease from the previous year. Operating cash flow comes from main business activities. Investors look for positive cash flow from recurring operating activities.
  • Cash Flow from investment activities: Zynerba Pharma used $-0.11M cash due to investment activities. It includes the use of cash outside of normal day to day activities like buying fixed assets, plant and machinery etc.
  • Inflow of cash in the form of bank loans and shareholders equity, and outflow of cash because of dividend payments, share repurchase payments etc. come under financing activities. The cash generated from these activities was $57.5M for Zynerba Pharma.

Key Financial Ratios For Zynerba Pharma Cash Flow

FCF margin
0

Annual Cash Flow Statements For Zynerba Pharmaceuticals Inc Peers

Marinus Pharma cash flow, Nemus Bioscience cash flow, Pfizer cash flow, SOL GEL TECH cash flow, Teligent cash flow